LONDON, Sept. 21, 2016 /PRNewswire/ -- Infectious diseases are caused by pathogens such as bacteria, viruses, fungi, and other parasites, which enter the body directly or indirectly through hosts or other vectors. Diagnostic tests are used to detect and determine the specific disease or condition. Diagnostic tests offer benefits such as rapid and precise results, which assist physicians in the diagnosis and treatment of various diseases.
Persistence Market Research report offers a forecast of the global infectious disease diagnostics market between 2016 and 2024. In terms of value, the market is expected to register a CAGR of 7.0% during the forecast period (2016–2024). This study demonstrates the market dynamics that are expected to influence the current environment and future status of the global infectious disease diagnostics market over the forecast period. It includes key trends, drivers, restraints, and opportunities influencing the growth of the global infectious diseases diagnostics market over the forecast period. Impact analysis of key growth drivers and restraints are included to better equip clients with crystal clear decision-making insights.
The global infectious disease diagnostics market has been segmented on the basis of:
By disease indication, the market is segmented into:
The STDs segment is estimated to account for a highest revenue share of 32.2% in 2016 and expected to register a higher CAGR as compared to other disease indication segments during the forecast period.
By technique, the market is segmented into:
Cell cultures segment revenue is expected to expand at highest CAGR of 35.5% over the forecast period.
By end user, the market is segmented into:
By region/country, the market is segmented into:
Rest of Latin America
Rest of Europe
Asia Pacific (APAC)
Australia & New Zealand
Rest of APAC
Middle East & Africa (MEA)
Rest of MEA
The APAC infectious disease diagnostics market is estimated to account for 26.5% revenue share in 2016 and expected to dominate the global infectious disease diagnostics market over the forecast period. APAC infectious disease diagnostics market is expected to register a higher CAGR as compared to markets in other regions.
Some key market participants included in the PMR's report are Thermo Fisher Scientific, Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Becton, Dickinson and Company, Hologic, Inc., Bio-Rad Laboratories, Inc. Quidel Corporation, bioMerieux SA, Alere, Inc., and Cepheid.
Download the full report: https://www.reportbuyer.com/product/4158741/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-market-study-on-infectious-diseases-diagnostics-increasing-demand-for-evidence--based-treatment-to-boost-demand-for-infectious-diagnostic-testing-during-forecast-period-300332055.html